RI-002, an intravenous immunoglobulin containing high titer neutralizing antibody to RSV and other respiratory viruses for use in primary immunodeficiency disease and other immune compromised populations-Reference-Cited by-同舟云学术

RI-002, an intravenous immunoglobulin containing high titer neutralizing antibody to RSV and other respiratory viruses for use in primary immunodeficiency disease and other immune compromised populations

Published:2017-10-16 Issue:12 Volume:13 Page:1107-1119
ISSN:1744-666X
Container-title:Expert Review of Clinical Immunology
language:en
Short-container-title:Expert Review of Clinical Immunology

Author:

Wasserman Richard L.¹,Greener Benjamin N.²,Mond James³

Affiliation:

1. Allergy Partners of North Texas Research, Dallas, TX, USA

2. Clinical Scientist – PPD Inc., 2400 Research Blvd., Rockville, MD, USA

3. Chief Medical and Scientific Officer- ADMA Biologics Inc., Ramsey, NJ, USA

Funder

AMDA Biologicals, Inc

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/1744666X.2017.1389647

Reference48 articles.

1. Practice parameter for the diagnosis and management of primary immunodeficiency

2. Optimizing immunoglobulin treatment for patients with primary immunodeficiency disease to prevent pneumonia and infection incidence: review of the current data

3. Impact of trough IgG on pneumonia incidence in primary immunodeficiency: A meta-analysis of clinical studies

4. Infection outcomes in patients with common variable immunodeficiency disorders: Relationship to immunoglobulin therapy over 22 years

5. Recurrent and persistent respiratory tract viral infections in patients with primary hypogammaglobulinemia

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Respiratory Syncytial Virus: Biology, Genetic Diversity, and Perspective Control Preparations;Molecular Genetics, Microbiology and Virology;2024-03

2. A molecular perspective for the development of antibodies against the human respiratory syncytial virus;Antiviral Research;2024-02

3. Respiratory-syncitial virus: biology, genetic diversity and perspective control preparations;Molecular Genetics Microbiology and Virology (Russian version);2024

4. Spirooxindole derivatives as promising antiviral agents: Structure–activity relationship studies and biological perspectives;Spirooxindole;2024

5. Fc-mediated functions and the treatment of severe respiratory viral infections with passive immunotherapy – a balancing act;Frontiers in Immunology;2023-11-22